Inventor · disambiguated record
Brant Clayton Boren
Also filed as: BOREN BRANT CLAYTON
11 granted patents·13 pending applications·133 citations·filing 2007–2024
87Inventor score
Files withRECURIUM IP HOLDINGS LLC15FIRMENICH INCORPORATED3BOLLU VENKATAIAH2ZENO MAN INC2EXELIXIS PATENT CO LLC1
Top patents by PatentIndex Score
24 records- 0196US10421727B2Compounds useful as modulators of TRPM8FIRMENICH INCORPORATED·Filed 2017·Granted Sep 24, 2019·88 cites·37 claims
- 0291US11261192B2Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Mar 1, 2022·5 cites·27 claims
- 0391US7998995B2LXR and FXR modulatorsEXELIXIS PATENT CO LLC·Filed 2007·Granted Aug 16, 2011·32 cites·45 claims
- 0480US2024391924A1Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 0579US11124518B2L,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-one analogsRECURIUM IP HOLDINGS LLC·Filed 2018·Granted Sep 21, 2021·2 cites·22 claims
- 0678US9840471B2Compounds useful as modulators of TRPM8SENOMYX INC·Filed 2014·Granted Dec 12, 2017·3 cites·23 claims
- 0769US8785488B2Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesityBOLLU VENKATAIAH·Filed 2010·Granted Jul 22, 2014·3 cites·14 claims
- 0869US2022024939A1Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 0968US11028052B2Compounds useful as modulators of TRPM8FIRMENICH INCORPORATED·Filed 2019·Granted Jun 8, 2021·0 cites·12 claims
- 1066US12410204B2Chiral synthesis of a tertiary alcoholRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Sep 9, 2025·0 cites·19 claims
- 1166US2024261295A1Combinations of wee1 inhibitors and anti-cd47 antibodiesRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 1264US2024299395A1Combination therapies comprising wee1 inhibitors and dna damage response (ddr) inhibitorsRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 1362US2021317124A11,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-one analogsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 1454US2023210854A1Mono- and combination therapiesRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 1554US2023234956A1Methods of making wee1 inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 1652US2023054854A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 1752US2023068370A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 1851US2023008362A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 1949US2023087941A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 2047US2023192720A1Macrocyclic compoundsZENO MAN INC·Filed 2020·Application pending·0 cites
- 2146US11339128B2Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiersFIRMENICH INCORPORATED·Filed 2015·Granted May 24, 2022·0 cites·38 claims
- 2246US11242327B2Analgesic compoundsRECURIUM IP HOLDINGS LLC·Filed 2018·Granted Feb 8, 2022·0 cites·23 claims
- 2346US2022144854A1Macrocyclic compoundsZENO MAN INC·Filed 2020·Application pending·0 cites
- 2431US8846739B2TGR5 agonistsBOLLU VENKATAIAH·Filed 2010·Granted Sep 30, 2014·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Brant Clayton Boren files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →